Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

HBM HEALTHCARE INVESTMENTS AG

(HBMN)
  Report
Delayed Quote. Delayed Swiss Exchange - 12/09 03:27:52 am
333 CHF   +0.91%
12/01HBM Healthcare Investments NAV Climbs 7% in Fiscal Year to November
MT
12/01Key Figures 30.11.2021
EQ
11/18INSIDER SELL : Harmony Biosciences Holdings
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

HBM Healthcare Investments AG Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021

10/22/2021 EST

HBM Healthcare Investments AG reported earnings results for the second quarter and six months ended September 30, 2021. For the second quarter, the company reported revenue was CHF 135.64 million compared to CHF 216.39 million a year ago. Net income was CHF 134.56 million compared to CHF 215.37 million a year ago. Basic earnings per share from continuing operations was CHF 19.34 compared to CHF 30.96 a year ago. For the six months, revenue was CHF 272.59 million compared to CHF 443.27 million a year ago. Net income was CHF 270.55 million compared to CHF 441.31 million a year ago. Basic earnings per share from continuing operations was CHF 38.89 compared to CHF 63.43 a year ago.


© S&P Capital IQ 2021
All news about HBM HEALTHCARE INVESTMENTS AG
12/01HBM Healthcare Investments NAV Climbs 7% in Fiscal Year to November
MT
12/01Key Figures 30.11.2021
EQ
11/18INSIDER SELL : Harmony Biosciences Holdings
MT
11/16Key Figures 15.11.2021
EQ
11/08HBM Healthcare's Portfolio Company IO Biotech Surges in US Nasdaq IPO
MT
11/02HBM Healthcare Investments NAV Rises 10% in Fiscal Year to October
MT
11/02Key Figures 31.10.2021
EQ
10/22HBM HEALTHCARE INVESTMENTS : Fiscal H1 Profit Drops Over Decline in Investment Value
MT
10/22HBM HEALTHCARE INVESTMENTS : Half-year Report September 2021
EQ
10/22HBM HEALTHCARE INVESTMENTS : Half-Year Report September 2021
PU
More news
Analyst Recommendations on HBM HEALTHCARE INVESTMENTS AG
More recommendations
Financials
Sales 2022 - - -
Net income 2022 171 M 186 M 186 M
Net Debt 2022 45,0 M 48,9 M 48,9 M
P/E ratio 2022 13,4x
Yield 2022 3,72%
Capitalization 2 296 M 2 490 M 2 492 M
EV / Sales 2022 -
EV / Sales 2023 -
Nbr of Employees 700
Free-Float 82,6%
Chart HBM HEALTHCARE INVESTMENTS AG
Duration : Period :
HBM Healthcare Investments AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HBM HEALTHCARE INVESTMENTS AG
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Last Close Price 330,00 CHF
Average target price 355,00 CHF
Spread / Average Target 7,58%
EPS Revisions
Managers and Directors
Andreas Wicki Chief Executive Officer
Erwin Troxler Chief Financial Officer
Hans-Peter Hasler Chairman
Rudolf Lanz Director
Mario Germano Giuliani Director
Sector and Competitors
1st jan.Capi. (M$)
HBM HEALTHCARE INVESTMENTS AG8.20%2 490
BLACKROCK, INC.27.63%139 904
BLACKSTONE INC.108.83%99 569
BROOKFIELD ASSET MANAGEMENT INC.38.96%92 541
UBS GROUP AG33.60%61 952
EQT AB (PUBL)139.16%54 411